Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEROPENEM ANHYDROUS vs MESALAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEROPENEM ANHYDROUS vs MESALAMINE: Safety Overview

Metric MEROPENEM ANHYDROUS MESALAMINE
Total FAERS Reports 144 19,475
Deaths Reported 25 1,744
Death Rate 17.4% 9.0%
Hospitalizations 102 6,015
Average Patient Age 55.0 yrs 49.8 yrs
% Female Patients 44.2% 46.7%
FDA Approval Date N/A Apr 14, 2025
Manufacturer Mylan Institutional LLC Upsher-Smith Laboratories, LLC
Route INTRAVENOUS ORAL
Marketing Status N/A Prescription